report cover

Women?s Health Drugs Market, Global Outlook and Forecast 2024-2030

  • 02 July 2024
  • Life Sciences
  • 62 Pages
  • Report code : 24WT-7966979

Women?s Health Drugs and Forecast Market

1 Introduction to Research & Analysis Reports
1.1 Women?s Health Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Women?s Health Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Women?s Health Drugs Overall Market Size
2.1 Global Women?s Health Drugs Market Size: 2023 VS 2030
2.2 Global Women?s Health Drugs Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Women?s Health Drugs Players in Global Market
3.2 Top Global Women?s Health Drugs Companies Ranked by Revenue
3.3 Global Women?s Health Drugs Revenue by Companies
3.4 Top 3 and Top 5 Women?s Health Drugs Companies in Global Market, by Revenue in 2023
3.5 Global Companies Women?s Health Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Women?s Health Drugs Players in Global Market
3.6.1 List of Global Tier 1 Women?s Health Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Women?s Health Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Women?s Health Drugs Market Size Markets, 2023 & 2030
4.1.2 EVISTA
4.1.3 XGEVA
4.1.4 Prolia
4.1.5 Mirena
4.1.6 Zometa
4.1.7 Reclast/Aclasta
4.1.8 Minastrin 24 Fe
4.1.9 Others (Premarin, ACTONEL, ORTHO TRI-CY LO)
4.2 By Type - Global Women?s Health Drugs Revenue & Forecasts
4.2.1 By Type - Global Women?s Health Drugs Revenue, 2019-2024
4.2.2 By Type - Global Women?s Health Drugs Revenue, 2025-2030
4.2.3 By Type - Global Women?s Health Drugs Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Women?s Health Drugs Market Size, 2023 & 2030
5.1.2 Hormonal Infertility
5.1.3 Postmenopausal Osteoporosis
5.1.4 Endometriosis
5.1.5 Contraceptives
5.1.6 Menopause
5.1.7 Polycystic Ovary Syndrome
5.1.8 Other Applications
5.2 By Application - Global Women?s Health Drugs Revenue & Forecasts
5.2.1 By Application - Global Women?s Health Drugs Revenue, 2019-2024
5.2.2 By Application - Global Women?s Health Drugs Revenue, 2025-2030
5.2.3 By Application - Global Women?s Health Drugs Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Women?s Health Drugs Market Size, 2023 & 2030
6.2 By Region - Global Women?s Health Drugs Revenue & Forecasts
6.2.1 By Region - Global Women?s Health Drugs Revenue, 2019-2024
6.2.2 By Region - Global Women?s Health Drugs Revenue, 2025-2030
6.2.3 By Region - Global Women?s Health Drugs Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Women?s Health Drugs Revenue, 2019-2030
6.3.2 US Women?s Health Drugs Market Size, 2019-2030
6.3.3 Canada Women?s Health Drugs Market Size, 2019-2030
6.3.4 Mexico Women?s Health Drugs Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Women?s Health Drugs Revenue, 2019-2030
6.4.2 Germany Women?s Health Drugs Market Size, 2019-2030
6.4.3 France Women?s Health Drugs Market Size, 2019-2030
6.4.4 U.K. Women?s Health Drugs Market Size, 2019-2030
6.4.5 Italy Women?s Health Drugs Market Size, 2019-2030
6.4.6 Russia Women?s Health Drugs Market Size, 2019-2030
6.4.7 Nordic Countries Women?s Health Drugs Market Size, 2019-2030
6.4.8 Benelux Women?s Health Drugs Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Women?s Health Drugs Revenue, 2019-2030
6.5.2 China Women?s Health Drugs Market Size, 2019-2030
6.5.3 Japan Women?s Health Drugs Market Size, 2019-2030
6.5.4 South Korea Women?s Health Drugs Market Size, 2019-2030
6.5.5 Southeast Asia Women?s Health Drugs Market Size, 2019-2030
6.5.6 India Women?s Health Drugs Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Women?s Health Drugs Revenue, 2019-2030
6.6.2 Brazil Women?s Health Drugs Market Size, 2019-2030
6.6.3 Argentina Women?s Health Drugs Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Women?s Health Drugs Revenue, 2019-2030
6.7.2 Turkey Women?s Health Drugs Market Size, 2019-2030
6.7.3 Israel Women?s Health Drugs Market Size, 2019-2030
6.7.4 Saudi Arabia Women?s Health Drugs Market Size, 2019-2030
6.7.5 UAE Women?s Health Drugs Market Size, 2019-2030
7 Women?s Health Drugs Companies Profiles
7.1 Bayer AG
7.1.1 Bayer AG Company Summary
7.1.2 Bayer AG Business Overview
7.1.3 Bayer AG Women?s Health Drugs Major Product Offerings
7.1.4 Bayer AG Women?s Health Drugs Revenue in Global Market (2019-2024)
7.1.5 Bayer AG Key News & Latest Developments
7.2 Allergan
7.2.1 Allergan Company Summary
7.2.2 Allergan Business Overview
7.2.3 Allergan Women?s Health Drugs Major Product Offerings
7.2.4 Allergan Women?s Health Drugs Revenue in Global Market (2019-2024)
7.2.5 Allergan Key News & Latest Developments
7.3 Merck & Co
7.3.1 Merck & Co Company Summary
7.3.2 Merck & Co Business Overview
7.3.3 Merck & Co Women?s Health Drugs Major Product Offerings
7.3.4 Merck & Co Women?s Health Drugs Revenue in Global Market (2019-2024)
7.3.5 Merck & Co Key News & Latest Developments
7.4 Pfizer Inc
7.4.1 Pfizer Inc Company Summary
7.4.2 Pfizer Inc Business Overview
7.4.3 Pfizer Inc Women?s Health Drugs Major Product Offerings
7.4.4 Pfizer Inc Women?s Health Drugs Revenue in Global Market (2019-2024)
7.4.5 Pfizer Inc Key News & Latest Developments
7.5 Amgen
7.5.1 Amgen Company Summary
7.5.2 Amgen Business Overview
7.5.3 Amgen Women?s Health Drugs Major Product Offerings
7.5.4 Amgen Women?s Health Drugs Revenue in Global Market (2019-2024)
7.5.5 Amgen Key News & Latest Developments
7.6 Agile Therapeutics Inc
7.6.1 Agile Therapeutics Inc Company Summary
7.6.2 Agile Therapeutics Inc Business Overview
7.6.3 Agile Therapeutics Inc Women?s Health Drugs Major Product Offerings
7.6.4 Agile Therapeutics Inc Women?s Health Drugs Revenue in Global Market (2019-2024)
7.6.5 Agile Therapeutics Inc Key News & Latest Developments
7.7 Ferring Pharmaceuticals
7.7.1 Ferring Pharmaceuticals Company Summary
7.7.2 Ferring Pharmaceuticals Business Overview
7.7.3 Ferring Pharmaceuticals Women?s Health Drugs Major Product Offerings
7.7.4 Ferring Pharmaceuticals Women?s Health Drugs Revenue in Global Market (2019-2024)
7.7.5 Ferring Pharmaceuticals Key News & Latest Developments
7.8 Mylan N.V.
7.8.1 Mylan N.V. Company Summary
7.8.2 Mylan N.V. Business Overview
7.8.3 Mylan N.V. Women?s Health Drugs Major Product Offerings
7.8.4 Mylan N.V. Women?s Health Drugs Revenue in Global Market (2019-2024)
7.8.5 Mylan N.V. Key News & Latest Developments
7.9 Lupin (India)
7.9.1 Lupin (India) Company Summary
7.9.2 Lupin (India) Business Overview
7.9.3 Lupin (India) Women?s Health Drugs Major Product Offerings
7.9.4 Lupin (India) Women?s Health Drugs Revenue in Global Market (2019-2024)
7.9.5 Lupin (India) Key News & Latest Developments
7.10 Eli Lilly And Company
7.10.1 Eli Lilly And Company Company Summary
7.10.2 Eli Lilly And Company Business Overview
7.10.3 Eli Lilly And Company Women?s Health Drugs Major Product Offerings
7.10.4 Eli Lilly And Company Women?s Health Drugs Revenue in Global Market (2019-2024)
7.10.5 Eli Lilly And Company Key News & Latest Developments
7.11 Novartis AG
7.11.1 Novartis AG Company Summary
7.11.2 Novartis AG Business Overview
7.11.3 Novartis AG Women?s Health Drugs Major Product Offerings
7.11.4 Novartis AG Women?s Health Drugs Revenue in Global Market (2019-2024)
7.11.5 Novartis AG Key News & Latest Developments
7.12 Johnson & Johnson
7.12.1 Johnson & Johnson Company Summary
7.12.2 Johnson & Johnson Business Overview
7.12.3 Johnson & Johnson Women?s Health Drugs Major Product Offerings
7.12.4 Johnson & Johnson Women?s Health Drugs Revenue in Global Market (2019-2024)
7.12.5 Johnson & Johnson Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Ask Our Expert

Leave This Empty:

*Required Information
List of Tables
Table 1. Women?s Health Drugs Market Opportunities & Trends in Global Market
Table 2. Women?s Health Drugs Market Drivers in Global Market
Table 3. Women?s Health Drugs Market Restraints in Global Market
Table 4. Key Players of Women?s Health Drugs in Global Market
Table 5. Top Women?s Health Drugs Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Women?s Health Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Women?s Health Drugs Revenue Share by Companies, 2019-2024
Table 8. Global Companies Women?s Health Drugs Product Type
Table 9. List of Global Tier 1 Women?s Health Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Women?s Health Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Women?s Health Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Women?s Health Drugs Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Women?s Health Drugs Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Women?s Health Drugs Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Women?s Health Drugs Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Women?s Health Drugs Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Women?s Health Drugs Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Women?s Health Drugs Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Women?s Health Drugs Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Women?s Health Drugs Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Women?s Health Drugs Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Women?s Health Drugs Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Women?s Health Drugs Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Women?s Health Drugs Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Women?s Health Drugs Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Women?s Health Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Women?s Health Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Women?s Health Drugs Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Women?s Health Drugs Revenue, (US$, Mn), 2025-2030
Table 30. Bayer AG Company Summary
Table 31. Bayer AG Women?s Health Drugs Product Offerings
Table 32. Bayer AG Women?s Health Drugs Revenue (US$, Mn) & (2019-2024)
Table 33. Bayer AG Key News & Latest Developments
Table 34. Allergan Company Summary
Table 35. Allergan Women?s Health Drugs Product Offerings
Table 36. Allergan Women?s Health Drugs Revenue (US$, Mn) & (2019-2024)
Table 37. Allergan Key News & Latest Developments
Table 38. Merck & Co Company Summary
Table 39. Merck & Co Women?s Health Drugs Product Offerings
Table 40. Merck & Co Women?s Health Drugs Revenue (US$, Mn) & (2019-2024)
Table 41. Merck & Co Key News & Latest Developments
Table 42. Pfizer Inc Company Summary
Table 43. Pfizer Inc Women?s Health Drugs Product Offerings
Table 44. Pfizer Inc Women?s Health Drugs Revenue (US$, Mn) & (2019-2024)
Table 45. Pfizer Inc Key News & Latest Developments
Table 46. Amgen Company Summary
Table 47. Amgen Women?s Health Drugs Product Offerings
Table 48. Amgen Women?s Health Drugs Revenue (US$, Mn) & (2019-2024)
Table 49. Amgen Key News & Latest Developments
Table 50. Agile Therapeutics Inc Company Summary
Table 51. Agile Therapeutics Inc Women?s Health Drugs Product Offerings
Table 52. Agile Therapeutics Inc Women?s Health Drugs Revenue (US$, Mn) & (2019-2024)
Table 53. Agile Therapeutics Inc Key News & Latest Developments
Table 54. Ferring Pharmaceuticals Company Summary
Table 55. Ferring Pharmaceuticals Women?s Health Drugs Product Offerings
Table 56. Ferring Pharmaceuticals Women?s Health Drugs Revenue (US$, Mn) & (2019-2024)
Table 57. Ferring Pharmaceuticals Key News & Latest Developments
Table 58. Mylan N.V. Company Summary
Table 59. Mylan N.V. Women?s Health Drugs Product Offerings
Table 60. Mylan N.V. Women?s Health Drugs Revenue (US$, Mn) & (2019-2024)
Table 61. Mylan N.V. Key News & Latest Developments
Table 62. Lupin (India) Company Summary
Table 63. Lupin (India) Women?s Health Drugs Product Offerings
Table 64. Lupin (India) Women?s Health Drugs Revenue (US$, Mn) & (2019-2024)
Table 65. Lupin (India) Key News & Latest Developments
Table 66. Eli Lilly And Company Company Summary
Table 67. Eli Lilly And Company Women?s Health Drugs Product Offerings
Table 68. Eli Lilly And Company Women?s Health Drugs Revenue (US$, Mn) & (2019-2024)
Table 69. Eli Lilly And Company Key News & Latest Developments
Table 70. Novartis AG Company Summary
Table 71. Novartis AG Women?s Health Drugs Product Offerings
Table 72. Novartis AG Women?s Health Drugs Revenue (US$, Mn) & (2019-2024)
Table 73. Novartis AG Key News & Latest Developments
Table 74. Johnson & Johnson Company Summary
Table 75. Johnson & Johnson Women?s Health Drugs Product Offerings
Table 76. Johnson & Johnson Women?s Health Drugs Revenue (US$, Mn) & (2019-2024)
Table 77. Johnson & Johnson Key News & Latest Developments
List of Figures
Figure 1. Women?s Health Drugs Segment by Type in 2023
Figure 2. Women?s Health Drugs Segment by Application in 2023
Figure 3. Global Women?s Health Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Women?s Health Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Women?s Health Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Women?s Health Drugs Revenue in 2023
Figure 8. By Type - Global Women?s Health Drugs Revenue Market Share, 2019-2030
Figure 9. By Application - Global Women?s Health Drugs Revenue Market Share, 2019-2030
Figure 10. By Type - Global Women?s Health Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Women?s Health Drugs Revenue Market Share, 2019-2030
Figure 12. By Application - Global Women?s Health Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Women?s Health Drugs Revenue Market Share, 2019-2030
Figure 14. By Region - Global Women?s Health Drugs Revenue Market Share, 2019-2030
Figure 15. By Country - North America Women?s Health Drugs Revenue Market Share, 2019-2030
Figure 16. US Women?s Health Drugs Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Women?s Health Drugs Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Women?s Health Drugs Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Women?s Health Drugs Revenue Market Share, 2019-2030
Figure 20. Germany Women?s Health Drugs Revenue, (US$, Mn), 2019-2030
Figure 21. France Women?s Health Drugs Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Women?s Health Drugs Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Women?s Health Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Women?s Health Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Women?s Health Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Women?s Health Drugs Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Women?s Health Drugs Revenue Market Share, 2019-2030
Figure 28. China Women?s Health Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Women?s Health Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Women?s Health Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Women?s Health Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. India Women?s Health Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Women?s Health Drugs Revenue Market Share, 2019-2030
Figure 34. Brazil Women?s Health Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Women?s Health Drugs Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Women?s Health Drugs Revenue Market Share, 2019-2030
Figure 37. Turkey Women?s Health Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Women?s Health Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Women?s Health Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Women?s Health Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. Bayer AG Women?s Health Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Allergan Women?s Health Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Merck & Co Women?s Health Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Pfizer Inc Women?s Health Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Amgen Women?s Health Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Agile Therapeutics Inc Women?s Health Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Ferring Pharmaceuticals Women?s Health Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Mylan N.V. Women?s Health Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Lupin (India) Women?s Health Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Eli Lilly And Company Women?s Health Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Novartis AG Women?s Health Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Johnson & Johnson Women?s Health Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)

Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SAMPLE REPORT INCLUDES
  • Industry Market SizeIndustry Market Size
  • SWOT AnalysisSWOT Analysis
  • Industry Major PlayersIndustry Major Players
  • Revenue ForecastsRevenue Forecasts
  • Historical and Forecast GrowthHistorical and Forecast Growth
  • Profitability AnalysisProfitability Analysis
SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Women?s Health Drugs and Forecast Market

Leave This Empty: